🇺🇸 FDA
Pipeline program

Panobinostat Capsules

CLBH589D2222

Phase 2 small_molecule completed

Quick answer

Panobinostat Capsules for Multiple Myeloma is a Phase 2 program (small_molecule) at pharmaand GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
pharmaand GmbH
Indication
Multiple Myeloma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials